Aspen Aerogels's revenue for the
three
months ended in Mar. 2026 was $37.9 Mil.
Its revenue for the trailing twelve months (TTM) ended in Mar. 2026 was $230.3 Mil.
Aspen Aerogels's Revenue per Share for the
three
months ended in Mar. 2026 was $0.46.
Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $2.79.
Warning Sign:
Aspen Aerogels Inc revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue per Share Growth Rate of Aspen Aerogels was -48.80% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -10.40% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 0.10% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -2.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Aspen Aerogels's highest 3-Year average Revenue per Share Growth Rate was 60.70% per year. The lowest was -16.80% per year. And the median was 0.65% per year.
Aspen Aerogels (NYSE:ASPN) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Aspen Aerogels Revenue Related Terms
Aspen Aerogels Revenue Historical Data
* Premium members only.
The historical data trend for Aspen Aerogels's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Building Products & Equipment subindustry, Aspen Aerogels's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aspen Aerogels Revenue vs Construction Industry
For the Construction industry and Industrials sector, Aspen Aerogels's Revenue distribution charts can be found below:
* The bar in red indicates where Aspen Aerogels's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $230.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aspen Aerogels (ASPN) has a Revenue of $230.3 Mil as of Mar. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Aspen Aerogels and its competitors.
Is Aspen Aerogels' Revenue too high?
Aspen Aerogels' current Revenue is $230.3 Mil. Overall, Aspen Aerogels has a GF Score™ of 68/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aspen Aerogels' Revenue compare to AIRJ and JLHL?
Aspen Aerogels' Revenue of $230.3 Mil can be compared against companies in the Construction industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Construction company?
A good Revenue depends on the Construction industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Aspen Aerogels and its competitors. Aspen Aerogels's current Revenue is $230.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aspen Aerogels stock overvalued right now?
Based on GuruFocus' analysis, Aspen Aerogels (ASPN) is currently considered Modestly Overvalued. The stock's GF Value™ is $5.10, compared to a current price of $5.70 — trading 11.7% above its estimated fair value. The current Revenue is $230.3 Mil. Aspen Aerogels' overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Aspen Aerogels (ASPN), the current Revenue is $230.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aspen Aerogels (ASPN) Overvalued in 2026?
Based on GuruFocus' analysis, Aspen Aerogels stock appears to be overvalued.
The current stock price of $5.70 is trading 11.7% above its estimated GF Value™ of $5.10.
GuruFocus considers Aspen Aerogels to be Modestly Overvalued.
Key valuation signals for ASPN:
Revenue: $230.3 Mil
GF Value™: $5.10 vs. price of $5.70 (11.7% above fair value)
No single metric tells the full story. See the ASPN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology, supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Thermal Barrier segment and the United States market. Some of its products include Pyrogel XTE, Cryogel Z, Spaceloft Subsea, and others.
68GF Score
Get the complete analysis for ASPN
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASPN has been successfully added to your 
